Evaluating the Driving Ability in Patients with Parkinson's Disease Using a Driving Simulator
スポンサーリンク
概要
- 論文の詳細を見る
Objective For patients with Parkinson's disease (PD), driving is challenging due to an impaired motor function and decreased attention capabilities. This study assessed the driving capacity in PD patients by comparing neurological signs. Methods The driving ability of PD patients was evaluated using a driving simulator (Safety Master NT-932) that tested the reaction time in response to traffic signals and steering wheel errors. We studied the correlations between the total Unified Parkinson's Disease Rating Scale (UPDRS) score, the UPDRS part III score, the subscores of the UPDRS part III score, age, PD disease duration, braking reaction time, steering wheel errors and total scores for driving safety test results. 'On' state regular PD licensed drivers (n=42; mean age: 63 years) in Hoehn and Yahr stages II-III participated after their cognitive status was confirmed using mini-mental state examinations. Results The UPDRS scores, the UPDRS part III scores and the postural instability subscores exhibited significant (p<0.05) correlations with the number of steering wheel errors but not with the braking reaction time or the total safety scores of the test results. Conclusion The UPDRS is an established evaluation method used to estimate PD signs, although it is not sufficient alone for deciding whether PD patients should be allowed to drive. Our findings suggest that determining the driving ability using a driving simulator might be a useful adjunct to UPDRS scores in the assessment of PD patients who are active drivers. Estimating the driving ability requires complex measurements, including motor performance with perception of stimuli and attention.
著者
-
Nomoto Masahiro
Department Of Clinical Pharmacology And Therapeutics Ehime University Graduate School Of Medicine
-
Nishikawa Noriko
Department Of Medicine Azumi General Hospital
-
IWAKI Hirotaka
Department of Therapeutic Medicine (Clinical Pharmacology and Neurology), Ehime University Graduate School of Medicine
-
Tsujii Tomoaki
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan
-
Nishikawa Noriko
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan
-
Thiri Kyaw
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan
-
Moritoyo Takashi
Phase I Unit, Clinical Trial Support Center, University of Tokyo Hospital, Japan
-
Iwaki Hirotaka
Department of Neurology and Clinical Pharmacology, Ehime University Graduate School of Medicine, Japan
関連論文
- Pathodynamics of Nitric Oxide Production Within Implanted Glioma Studied With an In Vivo Microdialysis Technique and Immunohistochemistry
- Properties of a Thin-Film Optical Waveguide Using Fluorinated Silicon Oxide and Organic Spin-on-Glass Films
- Quantification of Neuromodulin (GAP-43, B-50) and Synapsin I in Rat Striata
- Characteristic Upregulation of Dopamine D_1-Receptor in Rat Striatum after 6-Hydroxydopamine Treatment
- Risk Factors for Hospital-acquired Bacteremia
- Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
- Zonisamide Increases Dopamine Turnover in the Striatum of Mice and Common Marmosets Treated With MPTP
- Three Spinocerebellar Ataxia Type 2 Siblings with Ataxia, Parkinsonism, and Motor Neuronopathy
- Microarray Analysis of Laser Capture Microdissected Substantia Nigra Pars Compacta after a Single Administration of MPTP in Common Marmosets
- Proteasome Function and Pathological Proteins in the Pathogenesis of Parkinson's Disease
- Pharmacological Aspects of the Differences between the Caudate Nucleus and the Putamen
- THE EFFECTS OF BENZODIAZEPINES AND Ca-CHANNEL BLOCKERS ON OXOTREMORINE-INDUCED TREMORS IN MICE
- Effects of β-Blockers and Nicardipine on Oxotremorine-Induced Tremor in Common Marmosets
- Pigmented squamous cell carcinoma in situ of the conjunctiva
- Zonisamide Attenuates MPTP Neurotoxicity in Marmosets
- Pathodynamics of Nitric Oxide Production Within Implanted Glioma Studied With an In Vivo Microdialysis Technique and Immunohistochemistry
- Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum
- Pramipexole Upregulates Dopamine Receptor D_2 and D_3 Expression in Rat Striatum
- Evaluating the Driving Ability in Patients with Parkinson's Disease Using a Driving Simulator